Effects of a vitamin D3 analogue in a rat model of bladder outlet obstruction

BJU International

Volumn 98, Issue 3, 2006, Pages 637-642

  Schröder, Annette ^a,b   Colli, Enrico ^c   Maggi, Mario ^d   Andersson, Karl Erik ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c BioXell SpA   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Bladder hypertrophy; Bladder strips; Contractile function; Cystometry

Indexed keywords

BXL 628; CALCIUM; COLECALCIFEROL DERIVATIVE; POTASSIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CAPACITY; BLADDER CONTRACTION; BLADDER NECK STENOSIS; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTOMETRY; ELECTRIC FIELD; ELECTROSTIMULATION; FEMALE; MICTURITION; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; CALCITRIOL; ELECTRIC STIMULATION; FEMALE; HYPERTROPHY; MUSCLE CONTRACTION; ORGAN SIZE; POTASSIUM CHLORIDE; PRESSURE; RATS; RATS, SPRAGUE-DAWLEY; URINARY BLADDER; URINARY BLADDER NECK OBSTRUCTION; URINATION;

EID: 33746901138     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06342.x     Document Type: Article

References (17)

1. Gosling JA, Dixon JS. Structure of trabeculated detrusor smooth muscle in cases of prostatic hypertrophy. Urol Int 1980; 35: 351-5
2. Chapple CR, Milner P, Moss HE, Burnstock G. Loss of sensory neuropeptides in the obstructed human bladder. Br J Urol 1992; 70: 373-81
3. Levin RM, Chichester P, Hass M, Gosling JA, Buttyan R. Obstructive bladder dysfunction: morphological, biochemical and molecular changes. Eur Urol 2002; 41 (Suppl): 14-20
4. Andersson KE, Arner A. Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev 2004; 84: 935-86
5. Andersson KE. Storage and voiding symptoms: pathophysiologic aspects. Urology 2003; 62 (Suppl. 5): 3-10
6. Crescioli C, Maggie M, Vannelli GB et al. Effect of a vitamin D3 analogue on keratinocyte growth factor-induced cell proliferation in benign prostate hyperplasia. J Clin Endocrinol Metab 2000; 85: 2576-83
7. Crescioli C, Morelli A, Adorini L et al. Human bladder as a novel target for vitamin D receptor ligands. J Clin Endocrinol Metab 2005; 90: 962-72
8. Schroder A, Tajimi M, Matsumoto H, Schroder C, Brands M, Andersson KE. Protective effect of an oral endothelin converting enzyme inhibitor on rat detrusor function after outlet obstruction. J Urol 2004; 172: 1171-4
9. Schroder A, Uvelius B, Newgreen D, Andersson KE. Bladder overactivity in mice after 1 week of outlet obstruction. Mainly afferent dysfunction? J Urol 2003; 170: 1017-21
10. Azadzoi KM, Tarcan T, Kozlowski R, Krane RJ, Siroky MB. Overactivity and structural changes in the chronically ischemic bladder. J Urol 1999; 162: 1768-78
11. Brading AF, Greenland JE, Mills IW, McMurray G, Symes S. Blood supply to the bladder during filling. Scand J Urol Nephrol Suppl 1999; 201: 25-31
12. Greenland JE, Brading AF. The effect of bladder outflow obstruction on detrusor blood flow changes during the voiding cycle in conscious pigs. J Urol 2001; 165: 245-8
13. Brading A, Pessina F, Esposito L, Symes S. Effects of metabolic stress and ischaemia on the bladder, and the relationship with bladder overactivity. Scand J Urol Nephrol Suppl 2004; 215: 84-92
14. Malmgren A, Uvelius B, Andersson KE, Andersson PO. On the reversibility of functional bladder changes induced by infravesical outflow obstruction in the rat. J Urol 1990; 143: 1026-31
15. Seaman EK, Jacobs BZ, Blaivas JG, Kaplan SA. Persistence or recurrence of symptoms after transurethral resection of the prostate: a urodynamic assessment. J Urol 1994; 152: 935-7
16. Chai TC, Gemalmaz H, Andersson KE, Tuttle JB, Steers WD. Persistently increased voiding frequency despite relief of bladder outlet obstruction. J Urol 1999; 161: 1689-93
17. Crescioli C, Ferruzzi P, Caporali A et al. Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia. Eur J Endocrinol 2004; 150: 591-603